Boundless Bio

BOLDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$64.921 M

$2.89 +1.76%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$58.2M

Loss-making

Shares outstanding

22,747,985

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#338Annovis BioANVS$65.1M
#339Pliant TherapeuticsPLRX$65.0M
#340Boundless BioBOLD$64.9M
#341PMV PharmaceuticalsPMVP$63.5M
#342MindWalkHYFT$61.2M

Where these numbers come from

Share counts and financials for Boundless Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.